Richard K. Prins - 04 Jun 2021 Form 4 Insider Report for Amphastar Pharmaceuticals, Inc. (AMPH)

Role
Director
Signature
/s/ Eva Wen, by power of attorney
Issuer symbol
AMPH
Transactions as of
04 Jun 2021
Net transactions value
-$23,051
Form type
4
Filing time
08 Jun 2021, 20:59:52 UTC
Previous filing
14 May 2021
Next filing
23 Nov 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AMPH Common Stock Options Exercise $82,150 +5,000 +13% $16.43 44,160 04 Jun 2021 Direct
transaction AMPH Common Stock Sale $93,851 -5,000 -11% $18.77 39,160 04 Jun 2021 Direct F1
transaction AMPH Common Stock Options Exercise $82,150 +5,000 +13% $16.43 44,160 07 Jun 2021 Direct
transaction AMPH Common Stock Sale $93,500 -5,000 -11% $18.70 39,160 07 Jun 2021 Direct
transaction AMPH Common Stock Award $0 +6,019 +15% $0.000000 45,179 07 Jun 2021 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AMPH Stock Option (right to buy) Options Exercise $0 -5,000 -50% $0.000000 5,000 04 Jun 2021 Common Stock 5,000 $16.43 Direct F3
transaction AMPH Stock Option (right to buy) Options Exercise $0 -5,000 -100% $0.000000* 0 07 Jun 2021 Common Stock 5,000 $16.43 Direct F3
transaction AMPH Stock Option (right to buy) Award $0 +17,182 $0.000000 17,182 07 Jun 2021 Common Stock 17,182 $19.52 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.77 to $18.78, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
F2 The reported shares are represented by restricted stock units, or RSUs, all of which vest on June 7, 2022.
F3 Shares subject to the option are fully vested and immediately exercisable.
F4 All of the shares subject to the option vest on June 7, 2022.